In-Situ Hybridization Market Accelerates at 11.9% CAGR with Key Players Driving Game-Changing Tech and Revolutionizing Biomarker Discovery & Therapy Guidance

"The global In Situ Hybridization market reached US$ 9700.40 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 15087.46 million by 2031. The market is growing at a CAGR of 11.9% during the forecast period (2024-2031)." As per DataM intelligence research report

The In-Situ Hybridization Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth reports that help clients navigate complex market dynamics, drive strategic growth, and seize new opportunities in an ever-evolving global landscape.

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/in-situ-hybridization-market?sp

In-Situ Hybridization Market: Recent Industry Developments

USA

• FDA moved to lower regulatory burden on certain ISH test systems by proposing reclassification of ISH tests tied to approved oncology therapeutics from Class III to Class II (special controls), a step announced in June 2025.

• FDA formally classified fluorescence in-situ hybridization (FISH)-based detection of chromosomal abnormalities in hematologic malignancies as Class II in June 2025, aiming to improve patient access and reduce premarket burdens.

• Federal and HHS contracting activity included awards to spatial-biology and ISH-adjacent vendors, signaling government procurement interest in ISH technologies.

• Corporate developments in spatial biology included public company updates from major providers such as 10x Genomics and Bio-Techne, which highlighted spatial biology revenue trends in their July-August 2025 earnings.

• Grant and academic support programs from companies like NanoString and BioChain continued in mid-2025, supporting broader adoption of ISH-compatible workflows.

• Market reports from mid-2025 emphasized strong growth drivers for ISH, including precision oncology, spatial transcriptomics, and multiplexing, reinforcing investment interest across diagnostics and reagent suppliers.

Japan

• Sysmex received manufacturing and marketing approval in June 2025 for Japan's first PrismGuideTM APOE Genotyping Kit, an IVD designed to assess APOE genotypes to predict risk of amyloid-related imaging abnormalities with anti-amyloid β antibody drugs.

• Market reports from July 2025 highlighted continued growth of ISH and FISH probe segments in Japan, showing strong diagnostic adoption.

• Advanced Cell Diagnostics (Bio-Techne's ACD RNAscope) and other vendors actively participated in Japanese scientific meetings, including the Japanese Neuroscience Society exhibition in August 2025, showcasing RNA-ISH tools.

• Japanese companies such as Sysmex and its subsidiaries worked through mid-2025 on regulatory alignment and probe certification, ensuring stable supply of ISH probes in the market.

• Academic research from Japan in mid-2025 emphasized applied ISH and spatial transcriptomics studies, further driving demand for reagents and services.

In-Situ Hybridization Market: Drivers

The in-situ hybridization market is driven by rising demand for precision diagnostics in detecting cancer and genetic disorders. Growing cancer prevalence and rare conditions highlight ISH's role in accurate diagnosis and treatment planning. Advances such as high-resolution fluorescent ISH expand its applications across clinical and research settings. Increased investments in in-vitro diagnostics and the shift toward personalized medicine further boost adoption. Together, these factors make ISH an essential tool for targeted diagnostics.

Market growth is also supported by government funding, genomic research initiatives, and workflow automation that improves speed and accuracy. An aging population and rising cancer cases create steady demand, especially in developed regions. Increasing clinical awareness of ISH's value in guiding targeted therapies strengthens its use in oncology and beyond. With expanding adoption across hospitals, research institutes, and CROs, the market outlook remains highly promising.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/in-situ-hybridization-market?sp

Segment Covered in the In-Situ Hybridization Market:

➥ By Product: Consumables (Kits & Reagents, Probes, Accessories), Instruments, Software

➥ By Technology: FISH (DNA FISH, RNA FISH, PNA FISH), CISH

➥ By Application: Cancer Diagnostics, Cytology, Infectious Disease Diagnostics, Neuroscience, Immunology

➥ By End User: Hospitals & Diagnostic Laboratories, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, CROs

In-Situ Hybridization Market: Major Players

• Abbott Laboratories,

• F. Hoffmann-La Roche Ag,

• Becton,

• Dickinson And Company,

• Agilent Technologies, Inc,

• Thermo Fisher Scientific,

• Bio-Rad Laboratories, Inc,

• Bio-Techne Corporation,

• Creative Bioarray,

• Biocat Gmbh,

• Zytovision.

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=in-situ-hybridization-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.